| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |